Delivery Order SPE2DB20D1100-SPE2DB25FE0H6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,240.80 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed price delivery order represents a non-competitive procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used in military and federal healthcare systems to...
- The Defense Logistics Agency awarded a delivery order valued at $3,052.95 to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and is being fulfilled at the contractor's facility in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used by military service members and veterans through the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $12,196.14 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management, representing...
- The Defense Logistics Agency awarded a $2,906.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg on August 13, 2025, with an ultimate completion date of August 14, 2025. This non-competitive delivery order was fulfilled from AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a maximum value of $999,999,999.00 and extends through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $6,496.48 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used within military and...
- The Defense Logistics Agency awarded a delivery order valued at $39,850.61 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on August 12, 2025, with completion targeted for August 13, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used within military and...
- The Defense Logistics Agency awarded a delivery order valued at $11,632.89 to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Jardiance 10 mg tablets (90-count packages). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 23, 2025, with performance at the vendor's facility in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly prescribed for type 2 diabetes management, reflecting the critical pharmaceutical supply needs...
- The Defense Logistics Agency awarded a delivery order valued at $3,364.00 to AmerisourceBergen Drug Corp for Jardiance 10 mg tablets (90-count packages) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management, consistent...
- The Defense Logistics Agency awarded a delivery order valued at $4,765.67 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription medication used primarily for managing...
- The Defense Logistics Agency awarded a delivery order valued at $6,888.31 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 28, 2025, with completion scheduled for July 29, 2025. This competitive delivery order, which carries a firm fixed price structure and includes no set-aside designation, will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. Jardiance is a widely prescribed medication for type 2 diabetes management,...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE0H6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,191.99 to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 10 mg on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitive award uses firm fixed pricing with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription diabetes medication commonly used to treat type 2 diabetes in military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical supply agreement running through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies an extensive portfolio of brand-name and generic medications, vaccines, and medical devices to support Department of Defense health programs worldwide. The company's participation in DLA's pharmaceutical supply chain reflects its established capability to meet federal procurement requirements and serve military healthcare customers, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 8/13/25 |